The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer
Open Access
- 30 September 2016
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 6 (4) , 36
Abstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide and its prognosis remains poor. Molecular imaging with 18F-FDG PET/CT can metabolically characterize the nature of lesions as benign or malignant, allowing a better staging at the diagnosis of this kind of patient. This advantage can also be applied in the re-staging due to the suspicion of recurrent disease. Many patients have a recurrence of the disease, including surgically treated patients. In the current context, with new personalized oncological treatments, the surveillance for recurrence and its accurate diagnosis are crucial to improve their survival. In this paper, we revise the current knowledge about the clinical and molecular factors related to the recurrent disease. In the context of new, promising, available personalized treatments, the role of molecular imaging with PET/CT and 18F-FDG and non-18F-FDG radiotracers in the follow-up of NSCLC-treated patients is especially attractive and interesting.Keywords
This publication has 41 references indexed in Scilit:
- Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2016
- Nodal Stage of Surgically Resected Non-Small Cell Lung Cancer and Its Effect on Recurrence Patterns and Overall SurvivalInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non–Small Cell Lung CancerJournal of Nuclear Medicine, 2015
- Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non–Small Cell Lung CancerJournal of Nuclear Medicine, 2014
- Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures2013
- Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experienceEuropean Journal of Cardio-Thoracic Surgery, 2011
- Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger PatientsJournal of Thoracic Oncology, 2009
- Preoperative Staging of Lung Cancer with Combined PET–CTNew England Journal of Medicine, 2009
- PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.2004